Eli Lilly and the Menarini Group have both gotten the nod from the US Food and Drug Administration (FDA) for their new cancer medications. Lilly’s therapeutic for relapsed or refractory mantle cell lymphoma, called Jaypirca, is only the fourth drug of its kind approved by the agency. It will cost […]
Bristol Myers Reveals Positive Phase II Data for Leukemia CAR-T Cell Therapy Breyanzi
Bristol Myers Squibb has announced new clinical trial data for its leukemia CAR-T cell therapy Breyanzi. The data shows that the therapy has met its primary endpoint in the treatment of patients with relapsed or refractory chronic lymphocytic leukemia (CLL), beating standard care in complete […]
J&J and Legend’s CAR-T Therapy Better Than Standard Care in Phase III Trial
J&J and Legend Biotech have announced new results from their CARTITUDE-4 trial that shows their new CAR-T therapy Carvykti is more effective at treating multiple myeloma than standard care. The companies say that the therapy, which many predict to be an upcoming blockbuster, has achieved the […]
Oncology Telehealth Cuts Costs for Some Patients
A newly published paper in JAMA Network Open shows that some cancer patients saved significantly on travel costs by using telehealth oncology services. The study looked at completed telehealth visits from 11,688 adult patients up to 65 years of age and analyzed travel costs and loss of productivity […]
Real-World Data Study Shows Letrozole and Palbociclib Combo Effective for Black or Hispanic Breast Cancer Patients
Although frontline letrozole and palbociclib combination therapy did not improve survival for patients with estrogen receptor-positive, HER2-negative, advanced breast cancer in clinical trials, Black and/or Hispanic patients saw an increase in progression-free survival and overall survival. Dr. Adam […]
AstraZeneca Collaborates with Qure.ai for AI-Based Lung Cancer Diagnosis Pilot Trial
AstraZeneca has announced a new team-up with Qure.ai and a UK-based clinical team in a pilot trial to test the diagnostic capabilities of Qure.ai’s qXR software in identifying lung cancer from X-ray images. The trial will be held in clinics in Greater Manchester, which is noted for having some of […]
Real-World Data Study Finds Black and Hispanic Patients Receive Less Opioids During End-of-Life Care
A recently published study in the Journal of Clinical Oncology found that Black and Hispanic patients with cancer were significantly less likely to receive opioids during end-of-life care. In addition, the results, which came from nearly 320,000 Medicare patients 65 and older, also showed that Black […]
Modern Segregation in US Worsens Cancer Outcomes
In a newly published JAMA Oncology paper, researchers find that people living in US counties with higher levels of racial and socioeconomic segregation face a 20% increase in mortality rates. This effect was more pronounced in lung cancer, with mortality rates spiking by 50% in the most segregated […]
AJMC View: Balancing Cancer Treatment Innovation and Economic Burden
At The American Journal of Managed Care’s Institute for Value-Based Medicine event that took place this past October, speakers discussed the high cost of new therapeutics. A balance must be struck, according to Kevin Cohen, MD, of Optum Care, using data analytics to optimize care quality and […]
GAO Report Finds Certain Demographics Underrepresented in Cancer Drug Trials
A newly released report from the US Government Accountability Office finds that, despite years of health equity efforts, several key demographics are routinely underrepresented in clinical trials for new cancer therapeutics. This includes people with lower-incomes, rural residents, teens, older […]